ClearBridge Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

ClearBridge Investments’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-260	Closed	-$13K	–	1116
2015 Q4	$13K	Hold	260	–	–	﹤0.01%	1014
2015 Q3	$11K	Hold	260	–	–	﹤0.01%	1068
2015 Q2	$12K	Sell	260 -150	-37%	-$6.04K	﹤0.01%	1071
2015 Q1	$16K	Hold	410	–	–	﹤0.01%	1076
2014 Q4	$12K	Hold	410	–	–	﹤0.01%	1101
2014 Q3	$10K	Hold	410	–	–	﹤0.01%	1109
2014 Q2	$12K	Buy	410 +10	+3%	+$242	﹤0.01%	1110
2014 Q1	$10K	Buy	+400	New	+$10.7K	﹤0.01%	1078

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ClearBridge Investments's PTLA Position: Q1 2016 in Review

ClearBridge Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2016, closing a stake of 260 shares — an estimated $13K sold.

ClearBridge Investments first reported a position in PTLA in Q1 2014 and held it in 8 quarters. The position peaked at $16K in Q1 2015. 167 funds tracked by Wall St. Rank hold PTLA as of Q1 2016.

ClearBridge Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
ClearBridge Investments sold 260 Portola Pharmaceuticals, Inc. shares in Q1 2016, an estimated $13K.
ClearBridge Investments first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 8 quarters.
ClearBridge Investments's Portola Pharmaceuticals, Inc. position peaked at $16K in Q1 2015.
167 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2016.

Based on ClearBridge Investments's 13F filing for Q1 2016, filed 16 May 2016.